Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Osthoff

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Trials|January 5, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)Pascal Urwyler, Panteleimon Charitos, Stephan Moser, et al.
Frontiers in Immunology|November 15, 2023
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trialPascal Urwyler, Marina Leimbacher, Panteleimon Charitos, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2020
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma ConcentrationsCatia Marzolini, Felix Stader, Marcel Stoeckle, et al.
Journal of Intensive Care|January 19, 2021
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumoniaKirstine K Søgaard, Veronika Baettig, Michael Osthoff, et al.
Open Forum Infectious Diseases|October 18, 2021
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS SurveyKai-Manuel Adam, Michael Osthoff, Frédéric Lamoth, et al.
Annals of Internal Medicine|June 28, 2021
Effect of Bedside Compared With Outside the Room Patient Case Presentation on Patients' Knowledge About Their Medical Care : A Randomized, Controlled, Multicenter TrialChristoph Becker, Martina Gamp, Philipp Schuetz, et al.
Swiss Medical Weekly|January 24, 2022
Perception of physicians and nursing staff members regarding outside versus bedside ward rounds: ancillary analysis of the randomised BEDSIDE-OUTSIDE trialSebastian Gross, Katharina Beck, Christoph Becker, et al.
Journal of Medical Virology|December 14, 2020
Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measuresKaroline Leuzinger, Rainer Gosert, Kirstine K Søgaard, et al.
Frontiers in Microbiology|January 24, 2019
Discovery and Characterization of <i>Mycobacterium basiliense</i> sp. nov., a Nontuberculous Mycobacterium Isolated From Human LungsHelena M B Seth-Smith, Frank Imkamp, Florian Tagini, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2016
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant OrganismsElizabeth Temkin, Julian Torre-Cisneros, Bojana Beovic, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Trials|January 5, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)Pascal Urwyler, Panteleimon Charitos, Stephan Moser, et al.
Frontiers in Immunology|November 15, 2023
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trialPascal Urwyler, Marina Leimbacher, Panteleimon Charitos, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2020
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma ConcentrationsCatia Marzolini, Felix Stader, Marcel Stoeckle, et al.
Journal of Intensive Care|January 19, 2021
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumoniaKirstine K Søgaard, Veronika Baettig, Michael Osthoff, et al.
Open Forum Infectious Diseases|October 18, 2021
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS SurveyKai-Manuel Adam, Michael Osthoff, Frédéric Lamoth, et al.
Annals of Internal Medicine|June 28, 2021
Effect of Bedside Compared With Outside the Room Patient Case Presentation on Patients' Knowledge About Their Medical Care : A Randomized, Controlled, Multicenter TrialChristoph Becker, Martina Gamp, Philipp Schuetz, et al.
Swiss Medical Weekly|January 24, 2022
Perception of physicians and nursing staff members regarding outside versus bedside ward rounds: ancillary analysis of the randomised BEDSIDE-OUTSIDE trialSebastian Gross, Katharina Beck, Christoph Becker, et al.
Journal of Medical Virology|December 14, 2020
Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measuresKaroline Leuzinger, Rainer Gosert, Kirstine K Søgaard, et al.
Frontiers in Microbiology|January 24, 2019
Discovery and Characterization of <i>Mycobacterium basiliense</i> sp. nov., a Nontuberculous Mycobacterium Isolated From Human LungsHelena M B Seth-Smith, Frank Imkamp, Florian Tagini, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2016
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant OrganismsElizabeth Temkin, Julian Torre-Cisneros, Bojana Beovic, et al.
Pageof 12